What’s Actually Driving Your Testosterone Down? Signal Ep 3
May 12, 2026 - 59:29
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & PodcastsIn this free preview of the March 2026 Direct Line AMA. Drs. Feigenbaum and Baraki cover: VO2 max versus cardiorespiratory fitness for longevity (are Peter Attia’s targets evidence-based? — with Goodhart’s Law and the JA...
Episode #391: VO2 Max vs. Cardiorespiratory Fitness, GLP-1 Costs, and the 10,000-Step Myth Direct Line March 2026 (Free) is an episode from Barbell Medicine Podcast by Barbell Medicine. In this free preview of the March 2026 Direct Line AMA...
This episode belongs to Barbell Medicine Podcast.
Use the player on this page to stream the episode online.
Published Mar 24, 2026, 30:34 long, audio available.
In this free preview of the March 2026 Direct Line AMA. Drs. Feigenbaum and Baraki cover: VO2 max versus cardiorespiratory fitness for longevity (are Peter Attia’s targets evidence-based? — with Goodhart’s Law and the JAMA evidence), what GLP-1 medications actually cost now via manufacturer programs ($149–449/month), and whether 7,000–10,000 daily steps actually meet the bar for cardiovascular training. Full episode for Barbell Medicine Plus subscribers at Timestamps: 0:00 — Introduction 3:26 — VO2 Max vs. Cardiorespiratory Fitness for Longevity 14:11 — GLP-1 Costs: What you should actually be paying now 21:43 — Is Walking Enough for Cardiovascular Health? Next Steps: For evidence-based resistance training programs: barbellmedicine.com/training-programs For individualized training consultation: barbellmedicine.com/coaching Explore our full library of articles on health and performance: barbellmedicine.com/resources To consult with Drs. Baraki or Feigenbaum email us at support@barbellmedicine.com Resources: JAMA Network Open — Cardiorespiratory Fitness & Long-term Mortality (Mandsager et al.) — Exercise capacity (METs) and longevity — the foundational CRF/mortality study cited in the episode JAMA — Blair et al. — Physical fitness and all-cause mortality: a prospective study of healthy men and women Barbell Medicine Vital Five — Multi-modal CRF benchmarks and longevity targets Lilly Direct — Zepbound (tirzepatide) — Manufacturer direct program ($299–449/month) NovoCare — Wegovy (semaglutide) — Manufacturer savings program ($149–349/month) Orforglipron — Eli Lilly oral GLP-1 — What to know about orforglipron (small-molecule oral GLP-1 agonist, pending FDA approval) Our Sponsors: * Check out FIGS and use my code wearfigs.com for a great deal: * Check out Factor and use my code factormeals.com/bbm50off for a great deal: * Check out Quince and use my code quince.com/bbm for a great deal: Advertising Inquiries: Privacy & Opt-Out:
You can listen to Episode #391: VO2 Max vs. Cardiorespiratory Fitness, GLP-1 Costs, and the 10,000-Step Myth Direct Line March 2026 (Free) online on Radio and Podcast. Open the player on this page to stream the available audio.
Episode #391: VO2 Max vs. Cardiorespiratory Fitness, GLP-1 Costs, and the 10,000-Step Myth Direct Line March 2026 (Free) is an episode from Barbell Medicine Podcast by Barbell Medicine.
This episode is 30:34 long.
This episode was published on Mar 24, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Barbell Medicine Podcast when more episodes are available from the podcast feed.